期刊文献+

脂氧素与子宫内膜异位症 被引量:1

Lipoxins and Endometriosis
下载PDF
导出
摘要 子宫内膜异位症(endometriosis,EMs)为炎症性疾病和雌激素依赖性疾病,其具体发病机制尚不明确。脂氧素是具有生物活性的花生四烯酸代谢产物,在子宫内膜及异位内膜中均有表达。其可以通过抑制中性粒细胞的聚集和化学趋化作用,增强巨噬细胞的吞噬功能而达到抗炎促炎症消退的效果,并能与雌激素受体结合、调节雌激素相关基因从而参与调控雌激素效应。脂氧素可同时参与炎症反应和雌激素效应的网络调控,有效抑制EMs的病灶生长。介绍了脂氧素的生理功能和研究现状,并综述脂氧素在EMs发生发展过程中的作用。 Endometriosis (EMs) has been well known as an inflammatory and estrogen-dependent disease. However,its aetiology and pathogenesis are still ambiguous. Lipoxins, one of the endogenous metabolites of arachidonic acid,present in both eutopic and ectopic endometrium. Lipoxins actively promote resolution by restricting the polymorphonuclear (PMN) accumulation at the sites of inflammation, and enhancing macrophage phagocytosis. It can also bind with estrogen receptor (ER), and then modulate the expression of estrogen-related genes. Lipoxins can simultaneously modulate inflammation and estrogen signaling,and significantly inhibit the development of endometriosis. This article reviewed the biological function of lipoxins and its research progress, especially its role in the pathophysiology of EMs.
作者 陈硕 陈琼华
出处 《国际生殖健康/计划生育杂志》 CAS 2014年第1期56-59,共4页 Journal of International Reproductive Health/Family Planning
基金 厦门市科技计划项目(3502Z20134002) 福建省自然科学基金面上项目(2013D001)
关键词 子宫内膜异位症 脂氧素类 炎症 雌激素类 Endometriosis Lipoxins Inflammation Estrogens
  • 相关文献

参考文献37

  • 1陈琼华,曲军英,邱娜璇,许雅云,高凌云,郑伟.MMP9、TIMP1及VEGF在子宫内膜异位症患者在位内膜的表达[J].基础医学与临床,2004,24(4):418-421. 被引量:10
  • 2Serhan CN,Hamberg M,Samuelsson B. Lipoxins:novel series of biologically active compounds formed from arachidonic acid in human leukocytes[J].Proceedings of the National Academy of Sciences of the United States of America,1984,(17):5335-5339. 被引量:1
  • 3McMahon B,Godson C. Lipoxins:endogenous regulators of inflammation[J].American Journal of Physiology - Renal Physiology,2004,(02):F189-F201. 被引量:1
  • 4Serhan CN. Resolution phase of inflammation:novel endogenous anti-inflammatory and proresolving lipid mediators and pathways[J].Annual Review of Immunology,2007.101-137. 被引量:1
  • 5Russell R,Gori I,Pellegrini C. Lipoxin A4 is a novel estrogen receptor modulator[J].The FASEB Journal,2011,(12):4326-4337. 被引量:1
  • 6Madema P,Godson C. Lipoxins:resolutionary road[J].British Journal of Pharmacology,2009,(04):947-959. 被引量:1
  • 7Sethan CN,Nicolaou KC,Webber SE. Lipoxin A.Stereochemistry and biosynthesis[J].Journal of Biochemistry,1986,(35):16340-16345. 被引量:1
  • 8Serhan CN,Hamberg M,Samuelsson B. On the stereochemistry and biosynthesis of lipoxin B[J].Proceedings of the National Academy of Sciences of the United States of America,1986,(07):1983-1987. 被引量:1
  • 9Chiang N,Arita M,Serhan CN. Anti-inflammatory circuitry:Lipoxin,aspirin-triggered lipoxins and their receptor ALX[J].Prostaglandins, Leukotrienes & Essential Fatty Acids,2005,(3/4):163-177. 被引量:1
  • 10Motohashi E,Kawauchi H,Endo H. Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis[J].Biomedicine & Pharmacotherapy,2005,(06):330-338. 被引量:1

二级参考文献33

  • 1潘凌亚.子宫内膜异位症流行病学[A].郎景和.子宫内膜异位症的基础与临床研究[M].北京:中国协和医科大学出版社,2003,12.35-49. 被引量:3
  • 2Matalliotakis IM, Goumenou AG, Reteval, et al. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines[J]. Int Immunopharmacol ,2003,3 (1):81-89. 被引量:1
  • 3Gescher DM, Haensel A, Meyhofer-Malik A, et al. The importance of angiogenesis for the pathogenesis of endometriosis[J]. Zentralbl Gynakol ,2003,125:243-246. 被引量:1
  • 4Hofmann UB, Westphal JR, Van Kraats AA, et al. Expression of integrin alpha(v) beta (3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT-MMP1) and matrix metalloproteinase-2 (MMP-2) in human malanoma cells in vitro and in vivo[J]. Int J Cancer,2000,87(1):12-19. 被引量:1
  • 5Szamatowicz J, Laudanskip, Tomaszewska I, et al. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesrs of endometriosis[J]. Hum Reprod, 2002,17(2):284-288. 被引量:1
  • 6Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor[J]. Endocrine Rev, 1997,18(1):4-25. 被引量:1
  • 7Wu MY,Ho HN.The role of cytokines in endometriosis[J]. Am J Reprod Immunol,2002,49 (5):285-296. 被引量:1
  • 8Tan XJ, Lang JH, Liu DY, et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis[J]. Fertil Steril ,2002,78 (1):148-153. 被引量:1
  • 9Augoulea A,A lexandrou A,Creatsa M. Pathogenesis of endometriosis:the role of genetics,inflammation and oxidative stress[J].Archives of Gynecology and Obstetrics,2012,(01):99-103. 被引量:1
  • 10Rocha AL,Reis FM,Petraglia F. New trends for the medical treatment of endometriosis[J].Expert Opinion on Investigational Drugs,2012,(07):905-919. 被引量:1

共引文献20

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部